| Be sure to check out the new Product Showcases for O&P Professionals: |
|
|
AOPA H.R. 2479 Provisions Pending For Inclusion Senate Finance Bill from AOPA in Advance
AOPA Medicare O&P Improvement Act (similar to H.R. 2479) provisions were positioned for possible inclusion in Senate Finance Committee Medicare Reform bill. Senator Ron Wyden D-Ore., proposed the amendment that needed to be filed by 5 p.m., Friday, Sept. 18. Like all amendments, it would be subject to further scrutiny, and would be incorporated into the Senate health care reform bill only if voted upon favorably by the Senate Finance Committee. It's the next step in what has been a long and uncertain process of efforts to have O&P needs reflected in any final legislation signed into law by the President. More

Jordan Thomas and ACA featured on CNN Promoting Federal O&P Parity from CNN Click here to see the video from the Sept. 16 edition of the Situation Room with Wolf Blitzer.
URGENT: Immediate Action Required Regarding Accreditation and Surety Bonds
from AOPA in Advance
Deadlines for DMEPOS Accreditation and Surety Bonds are rapidly approaching. Failure to comply with these deadlines may result in the revocation of your Medicare billing Privileges. While many O&P Providers may be exempt from one or both of these requirements, it is urgent that you take the following action immediately. more
August 2009 Business Conditions Survey from AOPA in Advance
The August Business Conditions Survey is available. This month's questions focus on the use of business consultants by O&P patient care facility owners. Click here to take the survey.
College Park's Onyx® - Foot Balanced Energy, Ideal Comfort. Integrating a dynamic pylon, the multi-axial Onyx Foot allows active users to demand more. Highly customizable, the Onyx includes adjustable Stride Control for fine-tuning gait. The sleek Onyx delivers balanced energy with ideal comfort and enhanced terrain compliance. Three year warranty. Visit www.college-park.com or call 800.728.7950 for more information.
|
Upcoming Changes to the Orthopedic Shoe Policy from AOPA in Advance
Beginning Oct. 1 each claim line for orthopedic shoes must include the KX or the GY modifier. If the items you are providing meet the coverage criteria set forth in the policy, each claim line would include a KX modifier. If an item does not meet the coverage criteria or is a non-covered item (i.e. shoes not attached to a brace) the claim line must include the GY modifier and this claim line will be denied. Therefore, each shoe, insert or modification must include either the KX or the GY modifier. If a claim line doesn't include a modifier, then that line will be rejected and you will have to resubmit that claim line with the appropriate modifier.
 |
Supplier Showcase: Thuasne North America
Thuasne North America is very pleased to announce the acquisition of Thämert Germany. As a full distributor of Thuasne orthopedic, mastectomy, and sport products to Canada, United States, and Central America; we are excited to expand of our product offering with the addition of Thämert and Silima brands. For more information: www.thuasnena.com or www.thaermert.us.
|
 |
Product Showcase: OAK Orthotic Knee Joint
Feel the free-glide difference with the new OAK Orthotic Knee Joint from Fillauer! The OAK (Osteo-Arthritis Knee) polycentric orthotic knee joint has been engineered to provide motion that better approximates normal physiologic knee movement for use in a custom Osteoarthritic Knee Orthosis. Available in either Comfil® Thermo Formable Composite or Thermoplastic cuffs. More info
|
 |
Product Spotlight: Promenade Foot for Low Impact Amputees
The new Promenade from Freedom Innovations is designed specifically for low impact amputees. A dynamic heel and easily deflected toe provide near effortless roll-over, helping to reduce gait deviations and preserve energy. The full length sole plate provides a smooth transition from heel strike to toe off. Users achieve more symmetrical and efficient stride lengths allowing them to increase their activity and feel better. More info
|
|
|